Panel Discussion

Panel Discussion06（III-PD06）

Sun. Jul 11, 2021 10:00 AM - 12:10 PM Track6 (現地会場)

Chair: Hideo Ohuchi（National Cerebral and Cardiovascular Center, Japan）
Chair: Toshihide Nakano（Fukuoka Children’s Hospital, Japan）
Speaker/Commentator : David J Goldberg（ Perelman School of Medicine at the University of Pennsylvania/Children’s Hospital of Philadelphia, USA）

+Add all to schedule

[III-PD06-1] Hemodynamics after Fontan surgery causes metabolic and endocrine disorder

Kiyotaka Takefuta (Department of Pediatrics, International University of Health and Welfare Narita Hospital, Japan)

[III-PD06-2] Increased amygdala volume after Fontan operation

Rie Sato (Department of Pediatrics Japan Community Health care Organization Kyushu Hospital, Japan)

[III-PD06-3] An investigation about the change of transpulmonary pressure gradient in the Fontan patients

Toshikatsu Tanaka (Department of Cardiology, Hyogo Prefectural Kobe Children’s Hospital, Japan)

[III-PD06-4] Serum ammonia can predict Failed Fontan with high central venous pressure and cardiac output.

Hazumu Nagata (Department of Pediatrics, Kyushu University Hospital, Japan)

[III-PD06-5] The biomarkers for Fontan Associated End Organ Dysfunction -potential of red blood cell and platelet distribution width-

Hirofumi Saiki (Department of Pediatrics, Iwate Medical University, Japan)

[III-PD06-6] Pulmonary vasodilator might increase systemic to pulmonary flow and improve exercise capacity in the patient with Fontan circulation

Yuki Iwaya (Department of Cardiology, Fukuoka Childeren’s Hospital, Japan)

[III-PD06-7] Conduit stenosis ～ another pathway to the failing Fontan

Atsuko Kato (National Cerebral and Cardiovascular Center, Japan)

[III-PD06-8] The use of lymphangiographic imaging and liver lymphatic embolization as a treatment for refractory PLE in Fontan patients

Takayuki Oyanagi (Department of Pediatrics, Keio University, Japan)

Session information